Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy?

被引：0
|
作者：
Kubilay Karaboyun
Eyyup Cavdar
Yakup Irıagac
Abdussamet Celebı
Tanju Kapagan
Ilkay Gulturk
Ozden Demır
Okan Avcı
Erdogan Selcuk Seber
机构：
[1] Tekirdag Namik Kemal University,Department of Medical Oncology, School of Medicine
[2] Marmara University,Department of Medical Oncology, School of Medicine
[3] Basaksehir Cam and Sakura City Hospital,Department of Medical Oncology
[4] Bakirkoy Dr. Sadi Konuk Training and Research Hospital,Department of Medical Oncology
[5] Ondokuz Mayıs University,Department of Medical Oncology, School of Medicine
来源：
Supportive Care in Cancer | 2023年 / 31卷
关键词：
Urinary Incontinence; Early breast cancer; Adjuvant hormone therapy; Tamoxifen; Aromatase inhibitor; ICIQ-UI SF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
    Ellis, Georgiana K.
    Bone, Henry G.
    Chlebowski, Rowan
    Paul, Devchand
    Spadafora, Silvana
    Smith, Judy
    Fan, Michelle
    Jun, Susie
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) : 4875 - 4882
  • [22] RE: Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients Response
    Dackus, Gwen M. H. E.
    Jozwiak, Katarzyna
    Hauptmann, Michael
    Linn, Sabine C.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (01): : 167 - 168
  • [23] Cardiac outcomes in women receiving aromatase inhibitors as adjuvant endocrine therapy for breast cancer.
    Park, Esther
    Abu-Khalaf, Maysa M.
    Hatzis, Christos
    LaSala, Johanna M.
    Silber, Andrea
    Hofstatter, Erin Wysong
    Sanft, Tara Beth
    Russell, Raymond
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Endocrine adjuvant therapy in male breast cancer (MBC): tamoxifen (TAM), aromatase inhibitors (AI) or both?
    Cutuli, B.
    Cohen-Solal, C.
    Serin, D.
    Kirova, Y.
    Gaci, Z.
    Lemanski, C.
    De Lafontan, B.
    Zoubir, M.
    Maingon, P.
    Mignotte, H.
    de Lara, Tunon C.
    Edeline, J.
    Penault-Llorca, F.
    Romestaing, P.
    Delva, C.
    Belkacemi, Y.
    CANCER RESEARCH, 2009, 69 (02) : 290S - 290S
  • [25] Aromatase inhibitors in the adjuvant treatment of early breast cancer - Is there still a place for tamoxifen?
    Bergerat, Jean-Pierre
    PRESSE MEDICALE, 2007, 36 (02): : 333 - 340
  • [26] Aromatase inhibitors declared superior to tamoxifen in the adjuvant treatment of early breast cancer
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (09): : 1104 - 1105
  • [27] Comparison of the efficacy of tamoxifen and aromatase inhibitors on survival in adjuvant menopausal breast cancer
    Chay, W. Y.
    Speers, C.
    Gondara, L.
    Tyldesley, S.
    Ellard, S. L.
    Lohrisch, C. A.
    Gelmon, K. A.
    CANCER RESEARCH, 2016, 76
  • [28] A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI
    A. Lintermans
    K. Van Asten
    H. Wildiers
    A. Laenen
    R. Paridaens
    C. Weltens
    J. Verhaeghe
    D. Vanderschueren
    A. Smeets
    E. Van Limbergen
    K. Leunen
    M. R. Christiaens
    P. Neven
    Breast Cancer Research and Treatment, 2014, 146 : 109 - 116
  • [29] A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI
    Lintermans, A.
    Van Asten, K.
    Wildiers, H.
    Laenen, A.
    Paridaens, R.
    Weltens, C.
    Verhaeghe, J.
    Vanderschueren, D.
    Smeets, A.
    Van Limbergen, E.
    Leunen, K.
    Christiaens, M. R.
    Neven, P.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 146 (01) : 109 - 116
  • [30] Aromatase inhibitors as adjuvant therapies in patients with breast cancer
    Coombes, RC
    Gibson, L
    Hall, E
    Emson, M
    Bliss, J
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 86 (3-5): : 309 - 311
12345